BUZZ—US Stock Market Updates—MYR Group, Spyre Therapeutics, AMD
路透社2026/10/06 11:48Search string for querying individual stock trends: STXBZ "Today's Outlook" newsletter: https://refini.tv/3LI4BU7 "Morning News Briefing": https://refini.tv/3dKUyB8 Reuters, October 6 - U.S. stock index futures rose on Tuesday as Treasury yields retreated from multi-year highs and oil prices declined, providing a bit of relief for investors ahead of the quarterly earnings season. ** MYR Group MYRG.O: Market Spotlight — Jefferies upgraded MYR Group to "Buy"; stock price rose nL4N45S0PK ** Spyre Therapeutics SYRE.O: Market Action — Spyre Therapeutics shares fell due to a $350 millions stock offering nL6N45S0PG ** AMD.O: Market Action — AMD shares rose on plans to increase chip supply nL4N45S0Q7 ** Constellation Energy CEG.O: Highlight — Alphabet reportedly close to signing a multi-year nuclear energy deal, Constellation Energy shares climbed nL6N45S0HX ** Nike NKE.N: Highlight — Berenberg downgraded Nike to "Sell"; shares declined nL6N45S0KB ** Option Care Health OPCH.O: Highlight — Option Care Health surged after reportedly receiving a buyout offer exceeding $5 billions nL4N45S0L5 ** Freshworks Inc FRSH.O: Market Action — Freshworks stock advanced as it is set to be added to the S&P SmallCap 600 nL4N45S0IT (For the convenience of non-English speakers, Reuters automatically translates its reports into various other languages. As automatic translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of automated translations and provides them solely for readers' convenience. Reuters is not responsible for any damage or loss caused by the use of automatic translation features.)
.
Reuters, October 6 - On Tuesday, U.S. stock index futures rose as Treasury yields retreated from multi-year highs and oil prices fell, offering some relief to investors ahead of the quarterly earnings season..N
** MYR Group MYRG.O:
Market highlight — Jefferies upgraded MYR Group to “Buy”; shares rose nL4N45S0PK
** Spyre Therapeutics SYRE.O:
Market move — Spyre Therapeutics shares fell after $350 million stock offering nL6N45S0PG
** Advanced Micro Devices AMD.O:
Market move — AMD shares rose on plan to increase chip supply nL4N45S0Q7
** Constellation Energy CEG.O:
Highlight — Alphabet is reportedly close to a multi-year nuclear energy deal, Constellation Energy shares rose nL6N45S0HX
** Nike NKE.N:
Highlight — Berenberg downgraded Nike to “Sell”, shares declined nL6N45S0KB
** Option Care Health OPCH.O:
Highlight — Reportedly received an acquisition offer worth over $5 billion, Option Care Health shares surged nL4N45S0L5
** Freshworks Inc FRSH.O:
Market move — Freshworks gained ahead of inclusion in S&P SmallCap 600 index nL4N45S0IT
(To assist non-native English speakers, Reuters offers automated translation of its reports into several other languages. Because automated translation may contain errors or lack needed context, Reuters does not guarantee the accuracy of automated translation texts and provides them solely for the convenience of readers. Reuters assumes no responsibility for any damages or losses arising from the use of automated translation features.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Brent crude oil falls to $104 per barrel, down 0.2% in 24 hours.
The relevant page of Hyperliquid Labs lists 5 OTC buyer wallet addresses.
BUZZ - Preview: Levi's shares decline, market focuses on high-end jeans sales
On Wednesday, October 7, Levi Strauss (LEVI.N) shares fell 4.3% to $19.65 ahead of the company's quarterly earnings release after the market close. With consumer spending becoming more cautious, investors are closely watching the company's progress in entering the premium jeans market. According to data from the London Stock Exchange Group (LSEG), the apparel manufacturer—known for its jeans and casual wear—is expected to report third-quarter revenue growth of about 5% year-on-year to $1.62 billion, with adjusted earnings per share at $0.36, higher than last year's $0.34. Last quarter, the company raised its annual sales forecast, betting that its premium jeans would attract high-income consumers, though its earnings outlook disappointed some investors. Jefferies, in a preview report, anticipated the third-quarter results would be "solid" given strong demand for jeans, and pointed out that the appointment of a new chief financial officer signals continued focus on future global growth. On September 30, Levi's announced the appointment of John Vandemore as chief financial officer, effective November 1, 2026; Vandemore previously worked at Skechers, where he served as corporate controller and led the global finance team for the past nine years. In response to this news, Levi's shares have declined about 5% year-to-date and approximately 20% over the past 12 months. Out of 16 brokerage firms, 13 rate the stock as "strong buy" or "buy," while 3 have it as "hold"; the median target price remains at $27, unchanged over the last three months.
This AI Stock Exploded 600% in a Year, Beating Nvidia and Micron
Crypto prices
More
